ELAB (PMGC Holdings) EBITDA Margin %: -636.22% (As of Mar. 2026)


ELAB PMGC Holdings Inc ELAB
8 GF Score
Price $1.25
! 1 Warning Sign
View Full Analysis

What is PMGC Holdings EBITDA Margin %?

PMGC Holdings ELAB -4.94% 8 EBITDA Margin % is -636.22% as of Mar. 2026. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 945 Biotechnology companies, PMGC Holdings ranks worse than 77.57% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PMGC Holdings's EBITDA for the three months ended in Mar. 2026 was $-4.34 Mil. PMGC Holdings's Revenue for the three months ended in Mar. 2026 was $0.68 Mil. Therefore, PMGC Holdings's EBITDA margin for the quarter that ended in Mar. 2026 was -636.22%.

PMGC Holdings  (NAS:ELAB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PMGC Holdings EBITDA Margin % Related Terms

PMGC Holdings EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PMGC Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PMGC Holdings EBITDA Margin % Chart

PMGC Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
-78,200.00 -233.81 0.00 0.00 -1,253.39

PMGC Holdings Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -896.15 -882.89 -636.22

ELAB vs SYBX, CNSP, GNPX: EBITDA Margin % Comparison

For the Biotechnology subindustry, PMGC Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PMGC Holdings EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PMGC Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PMGC Holdings's EBITDA Margin % falls into.


ELAB
8GF Score
PMGC Holdings Inc ELAB
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PMGC Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PMGC Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.395/0.59
=-1,253.39 %

PMGC Holdings's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.339/0.682
=-636.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -636.22% mean?
PMGC Holdings (ELAB) has a EBITDA Margin % of -636.22% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PMGC Holdings and its competitors. According to the industry distribution chart, PMGC Holdings ranks #733 out of 945 companies in the Biotechnology industry, placing it in the top 77.6%.
Is PMGC Holdings' EBITDA Margin % too high?
PMGC Holdings' current EBITDA Margin % is -636.22%. Based on the distribution chart, PMGC Holdings ranks #733 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' EBITDA Margin % compare to SYBX and CNSP?
According to the Biotechnology industry distribution chart, PMGC Holdings ranks #733 out of 945 companies for EBITDA Margin %. This places PMGC Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PMGC Holdings and its competitors. PMGC Holdings's current EBITDA Margin % is -636.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current EBITDA Margin % of -636.22%. The current EBITDA Margin % is -636.22%. PMGC Holdings' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current EBITDA Margin % is -636.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMGC Holdings Business Description

Address C/O 120 Newport Center Drive, Suite 250, Newport Beach, CA, USA, 92660
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score

Get the complete analysis for ELAB

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25
Price